In Southern California, the power grid is always a hot topic. It's a part of the country that is all too familiar with the rolling blackouts. And now there is more reason for concern about the region's capacity to generate electricity. The San Onofre nuclear power plant is shutting down for good, thanks to worn-out parts. It's been off-line for more than a year after a pipe was found leaking radioactive steam. At its peak, San Onofre provided power for 1.4 million homes.
The man who leaked secret National Security Agency documents, Edward Snowden, defended his decision to reveal details of U.S. surveillance programs in a web chat on Monday. Snowden said he's still in Hong Kong and claims he wouldn't get a fair trial in the U.S. He also said he has not been in contact with the Chinese government and that there are more disclosures to come.
The U.S. Supreme Court on Monday struck down a state-mandated requirement that prospective voters in Arizona provide proof of citizenship to be able to register to vote in national elections. But some experts are concerned that the court may have inserted a few "poison pills" in its opinion that would damage voting-rights protections someday down the road.
The Supreme Court sided with government regulators in an important case involving the pharmaceutical industry and patent law. At issue were contracts between "brand-name" pharmaceutical companies and "generic" producers in which the brand-name company paid the generic not to compete. The court said the Federal Trade Commission could challenge such contracts.
The pendulum of this year's NBA finals has swung again. The first win in the series went to the San Antonio Spurs, the next to the Miami heat, then Spurs, then Heat. And last night, the Spurs won game five. That puts them one game away from winning their fifth NBA title, all with Gregg Popovich as their coach and all with Tim Duncan as one of their key players. But the series reverts to Miami tomorrow night. NPR's Mike Pesca will be there, and he joins us now. Hi, Mike.
You are listening to ALL THINGS CONSIDERED from NPR News.
A mother in New Jersey has set out to collect shoes, 3,792 pairs of shoes, one for each young person killed by gun violence in the U.S. in 1998. That was the year that her son was shot and killed as we hear from Sarah Gonzalez of New Jersey Public Radio.
SARAH GONZALEZ, BYLINE: Elaine Lane came up with the idea of collecting shoes after walking a path of military boots that represented lives lost in the Iraq War. She couldn't finish the trail, but it gave her an idea.
From NPR News, this is ALL THINGS CONSIDERED. I'm Melissa Block.
ROBERT SIEGEL, HOST:
And I'm Robert Siegel. We begin this hour with the annual Group of 8 summit in Northern Ireland. Today, President Obama and the other G8 leaders huddled at a resort there. Among the many topics, the bloody civil war in Syria. President Obama and Russian President Vladimir Putin sat down to talk about Syria, acknowledging that they have, as Mr. Obama said, differing perspectives.
When the maker of a brand-name drug pays a maker of generic drugs to not produce a lower-priced version of their product, the Federal Trade Commission can challenge the arrangement on antitrust grounds, the Supreme Court ruled Monday. The ruling may end the era of what regulators call "pay-for-delay" deals.
The justices voted 5-3 to allow a case to go forward in which the FTC is challenging one of many such deals. Several companies are involved in the case, including Solvay Pharmaceuticals, maker of AndroGel, and generic-drug maker Actavis.